Article ; Online: Managed care opportunities and approaches to select treatment for sight preservation.
The American journal of managed care
2022 Volume 28, Issue 3 Suppl, Page(s) S44–S51
Abstract: Anti-vascular endothelial growth factor therapies have become the mainstay of treatment for both diabetic macular edema and neovascular age-related macular degeneration. This treatment is imperative for vision preservation including visual acuity. ... ...
Abstract | Anti-vascular endothelial growth factor therapies have become the mainstay of treatment for both diabetic macular edema and neovascular age-related macular degeneration. This treatment is imperative for vision preservation including visual acuity. However, treatment burdens include high costs, frequent injections, continued visual loss, and loss of ability to perform day-to-day functions. Although clinical trial data have provided insights to treatment options and protocols, real-world patient experiences and adherence to therapies do not often mimic clinical trials as patients cannot fully adhere to their treatment schedule, leading to poor disease outcomes. Payers may consider various strategies such as step therapies, fee schedule management, and driving utilization through specialty pharmacies to contain costs. However, it is important to recognize not all patients will respond to a one-size-fits-all approach to treatment, warranting a more personalized approach. |
---|---|
MeSH term(s) | Angiogenesis Inhibitors ; Diabetic Retinopathy/therapy ; Humans ; Intravitreal Injections ; Macular Degeneration/drug therapy ; Macular Edema/drug therapy ; Managed Care Programs ; Ranibizumab/therapeutic use ; Vascular Endothelial Growth Factor A ; Wet Macular Degeneration/drug therapy |
Chemical Substances | Angiogenesis Inhibitors ; Vascular Endothelial Growth Factor A ; Ranibizumab (ZL1R02VT79) |
Language | English |
Publishing date | 2022-03-11 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2035781-3 |
ISSN | 1936-2692 ; 1088-0224 ; 1096-1860 |
ISSN (online) | 1936-2692 |
ISSN | 1088-0224 ; 1096-1860 |
DOI | 10.37765/ajmc.2022.88854 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5353: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MG 86: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.